N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised

Sponsor: Pfizer • ClinicalTrials.gov ID: NCT07013474

Registry updated: 2026-10-14
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

This is a Phase 3, randomized, actively controlled, double-blinded, double-dummy, superiority study to evaluate the efficacy and safety of ibuzatrelvir alone and in combination with remdesivir IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who are non-hospitalized or are hospitalized at baseline with mild-to-moderate COVID-19.

Interventions

  • ibuzatrelvir (Drug)
    tablet
  • remdesivir (Drug)
    injection, for intravenous use
  • placebo for ibuzatrelvir (Drug)
    tablet
  • placebo for remdesivir (Drug)
    injection, for intravenous use

Eligibility criteria

Inclusion Criteria: 1. 18 years of age or older at screening who are non-hospitalized or hospitalized with mild to moderate COVID-19 2. Confirmed SARS-CoV-2 infection as determined by RAT (or other locally approved test) collected within 2 days prior to randomization. Initial onset of symptoms attributable to COVID-19 within 5 days prior to the day of randomization and at least 1 of the specified symptoms attributable to COVID-19 present on the day of randomization. 3. Severely immunocompromised due to: * Solid organ or islet cell transplant recipient who is receiving immunosuppressive therapy; * Active hematologic malignancy (eg, chronic lymphocytic leukemia, non-Hodgkin lymphoma, multiple myeloma, acute leukemia); * Receipt of CAR-T-cell therapy or HCT either within 2 years of transplantation or who are receiving immunosuppressive therapy; * Currently receiving or recently received B-cell depleting therapies (eg, rituximab), where the immunosuppressive effect is still ongoing. Exclusion Criteria: 1. Severe or critical COVID-19, or current need for supplemental oxygen. 2. Receiving dialysis or have current kidney failure (ie, eGFR consistently \<15 mL/min) 3. Active liver disease 4. History of hypersensitivity or other contraindication to any of the components of the study interventions, as determined by the investigator 5. Suspected or confirmed concurrent active systemic infection other than COVID-19 that may interfere with the evaluation of response to the study intervention. 6. Life expectancy less than 30 days at study entry due to an underlying condition, in the judgement of the investigator. 7. Any medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or, in the investigator's judgment, make the participant inappropriate for the study. 8. Has received any other antiviral for the treatment of the current COVID-19 infection 9. Current use of any prohibited concomitant medication(s) or unwillingness or inability to use a required concomitant medication(s). 10. Current or previous administration of an investigational product (drug or vaccine) within 30 days (or as determined by local requirement) or 5 half lives preceding the first dose of study intervention used in this study (whichever is longer). Authorized or products with conditional approval are not considered investigational. 11. Prior participation in this trial or any clinical trial of ibuzatrelvir. 12. Females who are pregnant, breastfeeding, or who are planning to become pregnant within the timeframe of the study. 13. Investigator site staff directly involved in the conduct of the study and their family members, site staff otherwise supervised by the investigator, and sponsor and sponsor delegate employees directly involved in the conduct of the study and their family members.

Conditions

COVID-19 Infection

Locations

  • Hope Clinical Research, Inc. — Canoga Park, California, United States
  • Amicis Research Center - Granada Hills — Granada Hills, California, United States
  • Jacobs Medical Center at UC San Diego Health — La Jolla, California, United States
  • UC Davis CTSC Clinical Research Center — Sacramento, California, United States
  • University of California Davis Health — Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest — San Diego, California, United States
  • University of California San Diego Health — San Diego, California, United States
  • UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus — Aurora, Colorado, United States
  • University of Colorado Anschutz Medical Campus — Aurora, Colorado, United States
  • University of Colorado Clinical and Translational Research Center — Aurora, Colorado, United States
  • University of Colorado Hospital — Aurora, Colorado, United States
  • Georgetown University Medical Center — Washington D.C., District of Columbia, United States
  • BRP- Hialeah Hospital — Hialeah, Florida, United States
  • D&H Cancer Research Center LLC — Margate, Florida, United States
  • Kendall South Medical Center — Miami, Florida, United States
  • Velocity Clinical Research, Savannah — Savannah, Georgia, United States
  • Humphreys Diabetes Center — Boise, Idaho, United States
  • St. Luke's Idaho Elks Children's Pavilion — Boise, Idaho, United States
  • Northwestern Memorial Hospital — Chicago, Illinois, United States
  • Northwestern University Feinberg School of Medicine — Chicago, Illinois, United States
  • Johns Hopkins Hospital — Baltimore, Maryland, United States
  • Jadestone Clinical Research — Silver Spring, Maryland, United States
  • Brigham and Women's Hospital — Boston, Massachusetts, United States
  • Clinical Trials Center — Boston, Massachusetts, United States
  • Clinical Trials Hub — Boston, Massachusetts, United States
  • University of Massachusetts Chan Medical School — Worcester, Massachusetts, United States
  • University of Michigan — Ann Arbor, Michigan, United States
  • Henry Ford Hospital — Detroit, Michigan, United States
  • Holy Name Medical Center — Teaneck, New Jersey, United States
  • NYU Langone Health — New York, New York, United States
  • Duke Vaccine and Trials Unit — Durham, North Carolina, United States
  • Duke Vaccine and Trials Unit — Durham, North Carolina, United States
  • Duke University - Main Hospital and Clinics — Durham, North Carolina, United States
  • University of Cincinnati Medical Center — Cincinnati, Ohio, United States
  • University of Cincinnati College of Medicine (UC Holmes) — Cincinnati, Ohio, United States
  • TRC — Pittsburgh, Pennsylvania, United States
  • University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania, United States
  • UPMC Division of Infectious Disease Clinic — Pittsburgh, Pennsylvania, United States
  • UPMC Presbyterian IDS — Pittsburgh, Pennsylvania, United States
  • UPMC Presbyterian Shadyside — Pittsburgh, Pennsylvania, United States
  • UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
  • UPMC Shadyside IDS — Pittsburgh, Pennsylvania, United States
  • UPMC Shadyside — Pittsburgh, Pennsylvania, United States
  • Medical University of South Carolina Infectious Disease Clinic — Charleston, South Carolina, United States
  • Medical University of South Carolina Investigational Drug Services (IDS) — Charleston, South Carolina, United States
  • Medical University of South Carolina Investigational Drug Services Pharmacy — Charleston, South Carolina, United States
  • Medical University of South Carolina Research Nexus Clinic — Charleston, South Carolina, United States
  • Medical University of South Carolina Translational Research Nexus Clinic and Laboratory — Charleston, South Carolina, United States
  • Medical University of South Carolina — Charleston, South Carolina, United States
  • West Tennessee Research Institute — Jackson, Tennessee, United States
  • Zenos Clinical Research — Dallas, Texas, United States
  • Baylor Scott & White Health - Center for Advanced Heart and Lung Disease — Dallas, Texas, United States
  • Baylor Scott & White Research Institute - Clinical Trials Office — Dallas, Texas, United States
  • Baylor University Medical Center — Dallas, Texas, United States
  • Cockrell Center for Advanced Therapeutics — Houston, Texas, United States
  • Houston Methodist - Transplant Center — Houston, Texas, United States
  • Houston Methodist Hospital — Houston, Texas, United States
  • Memorial Hermann Hospital — Houston, Texas, United States
  • Scurlock CCAT clinic — Houston, Texas, United States
  • The University of Texas Health Science Center at Houston — Houston, Texas, United States
  • UT Physicians — Houston, Texas, United States
  • Seattle Rheumatology Associates — Seattle, Washington, United States
  • Swedish Ambulatory Infusion Center- First Hill — Seattle, Washington, United States
  • Swedish Cancer Institute Treatment Center — Seattle, Washington, United States
  • Swedish Medical Center- Innovative Therapeutics & Research Unit — Seattle, Washington, United States
  • Swedish Organ Transplant and Liver Center — Seattle, Washington, United States
  • Fred Hutchinson Cancer Center — Seattle, Washington, United States
  • Fred Hutchinson South Lake Union Clinic — Seattle, Washington, United States
  • Swedish Medical Center - First Hill Campus — Seattle, Washington, United States
  • University of Washington Medical Center — Seattle, Washington, United States
  • Hospital Italiano de La Plata — La Plata, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires — ABB, Buenos Aires F.D., Argentina
  • Instituto Médico Río Cuarto — Río Cuarto, Córdoba Province, Argentina
  • Sanatorio Sagrado Corazón — Buenos Aires, Argentina
  • UZ Brussel — Brussels, Brussels Capital, Belgium
  • Université Libre de Bruxelles - Hôpital Erasme — Brussels, Bruxelles-capitale, Région de, Belgium
  • AZ Sint-Jan Brugge-Oostende AV — Bruges, West-vlaanderen, Belgium
  • Jules Bordet Institute — Anderlecht, Belgium
  • School of Medicine Federal University of Minas Gerais — Belo Horizonte, Minas Gerais, Brazil
  • Hospital Nossa Senhora das Graças — Curitiba, Paraná, Brazil
  • Centro Médico São Francisco — Curitiba, Paraná, Brazil
  • Hospital de Clinicas de Porto Alegre — Bairro Santa Cecília, Rio Grande do Sul, Brazil
  • Hospital e Maternidade Celso Pierro — Campinas, São Paulo, Brazil
  • CECIP - Centro de Estudos do Interior Paulista — Jaú, São Paulo, Brazil
  • Instituto Nacional de Infectologia Evandro Chagas — Rio de Janeiro, Brazil
  • Icesp - Instituto Do Câncer Do Estado de São Paulo — São Paulo, Brazil
  • Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein — São Paulo, Brazil
  • Rigshospitalet — Copenhagen, Capital Region, Denmark
  • Aarhus Universitetshospital, Skejby — Aarhus, Central Jutland, Denmark
  • Odense Universitetshospital — Odense, Region Syddanmark, Denmark
  • Aalborg Universitetshospital, Syd — Gistrup, Denmark
  • Hopital Claude Huriez - CHU de Lille — Lille, NORD, France
  • Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand — Dijon, France
  • Hôpital Saint Antoine — Paris, France
  • Hôpital Bichat - Claude-Bernard — Paris, France
  • Hôpital Saint-Louis — Paris, Île-de-France Region, France
  • TUM Klinikum — München, Bavaria, Germany
  • Universitaetsklinikum Koeln — Cologne, North Rhine-Westphalia, Germany
  • UKE Hamburg — Hamburg, Germany
  • Universitaetsmedizin Rostock — Rostock, Germany
  • Klinikum Mutterhaus der Borromaerinnen gGmbH — Trier, Germany
  • Kliniken Villingen-Schwenningen — Villingen-Schwenningen, Germany
  • HELIOS Klinikum Wuppertal — Wuppertal, Germany
  • University General Hospital of Alexandroupoli — Alexandroupoli, Anatolikí Makedonía KAI Thráki, Greece
  • Evangelismos General Hospital of Athens — Athens, Attikí, Greece
  • Alexandra General Hospital of Athens — Athens, Attikí, Greece
  • General Hospital of Athens "Laiko" — Athens, Attikí, Greece
  • University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA" — Chaïdári, Greece
  • University General Hospital of Heraklion — Irakleio, Greece
  • Ippokrateio General Hospital of Thessaloniki — Thessaloniki, Greece
  • Fujita Health University Hospital — Toyoake, Aichi-ken, Japan
  • International University of Health and Welfare Narita Hospital — Narita, Chiba, Japan
  • Aso Iizuka Hospital — Iizuka, Fukuoka, Japan
  • Rinku General Medical Center — Izumisano, Osaka, Japan
  • Tokyo Medical University Hachioji Medical Center — Hachiōji, Tokyo, Japan
  • National Center for Global Health and Medicine — Shinjuku, Tokyo, Japan
  • Tachikawa Hospital — Tachikawa, Tokyo, Japan
  • National Hospital Organization Kyushu Medical Center — Fukuoka, Japan
  • Nagasaki University Hospital — Nagasaki, Japan
  • Saga University Hospital — Saga, Japan
  • Fundación Santos y de la Garza Evia I.B.P — San Pedro Garza García, Nuevo León, Mexico
  • FAICIC S. de R.L. de C.V. — Veracruz, Veracruz Ignacio de LA Llave, Mexico
  • Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran — Mexico City, Mexico
  • Radboudumc — Nijmegen, Netherlands
  • Erasmus MC — Rotterdam, Netherlands
  • BRCR Global Puerto Rico — Ponce, Puerto Rico
  • BRCR Global Puerto Rico — San Juan, Puerto Rico
  • Fakultna nemocnica s poliklinikou F.D.Roosevelta Banska Bystrica — Banská Bystrica, Banská Bystrica Region, Slovakia
  • Narodny ustav detskych chorob — Bratislava, Bratislava Region, Slovakia
  • Fakultna nemocnica Trnava — Trnava, Trnava Region, Slovakia
  • Narodny onkologicky ustav — Bratislava, Slovakia
  • Nemocnica s poliklinikou Stefana Kukuru Michalovce, a.s. — Michalovce, Slovakia
  • Gachon University Gil Medical Center — Namdong-gu, Incheon-gwangyeoksi [incheon], South Korea
  • Chonnam National University Hospital — Gwangju, Kwangju-kwangyǒkshi, South Korea
  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital — Seoul, Seoul-teukbyeolsi [seoul], South Korea
  • Asan Medical Center — Seoul, Seoul-teukbyeolsi [seoul], South Korea
  • CHUAC-Complejo Hospitalario Universitario A Coruña — A Coruña, A Coruña [LA Coruña], Spain
  • Hospital Universitario Reina Sofia — Córdoba, Andalusia, Spain
  • Hospital Germans Trias i Pujol — Badalona, Barcelona [barcelona], Spain
  • Parc de Salut Mar - Hospital del Mar — Barcelona, Barcelona [barcelona], Spain
  • Hospital Universitari Vall d'Hebron — Barcelona, Barcelona [barcelona], Spain
  • Hospital de la Santa Creu i Sant Pau — Barcelona, Catalunya [cataluña], Spain
  • Hospital Universitario La Paz — Madrid, Madrid, Comunidad de, Spain
  • CHUVI- Hospital Alvaro Cunqueiro — Vigo, Pontevedra [pontevedra], Spain
  • Hospital General Universitario Dr. Balmis — Alicante, Spain
  • Hospital Universitario Virgen de Valme — Seville, Spain
  • Skånes Universitetssjukhus Malmö — Malmö, Skåne LÄN [se-12], Sweden
  • Karolinska Universitetssjukhuset Huddinge — Huddinge, Sweden
  • Far Eastern Memorial Hospital — New Taipei City, NEW Taipei, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City, Taiwan
  • Taichung Veterans General Hospital — Taichung, Taiwan
  • Taipei Veterans General Hospital — Taipei, Taiwan
  • Acibadem Universitesi Atakent Hastanesi — Istanbul, İ̇stanbul, Turkey (Türkiye)
  • Hacettepe Universite Hastaneleri — Ankara, Turkey (Türkiye)
  • Ibni Sina Hospital — Ankara, Turkey (Türkiye)
  • Gaziantep Universitesi Sahinbey Arastirma ve Uygulama Hastanesi — Gaziantep, Turkey (Türkiye)
  • Kocaeli Üniversitesi — Kocaeli, Turkey (Türkiye)
  • Sakarya Training and Research Hospital — Sakarya, Turkey (Türkiye)
  • Karadeniz Technical University — Trabzon, Turkey (Türkiye)
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record